Showing results (11-20 of 389) with videos related to
Sort By:
Pageof 39
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Exploring new pathways in endocrine-resistant breast cancerInês Soares de Pinho, Catarina Abreu, Inês Gomes, et al.Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Emerging role of pioneer transcription factors in targeted ERα positive breast cancerHoney Pavithran, Ranjith KumavathExploration of Targeted Anti-Tumor Therapy|September 1, 2022
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLCLuca Cantini, Federica Pecci, Filippo Merloni, et al.Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Immunotherapy in gynecological cancersDomenica Lorusso, Valentina Ceni, Gennaro Daniele, et al.Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Multi-omics tumor profiling technologies to develop precision medicine in multiple myelomaSara Ovejero, Jerome MoreauxExploration of Targeted Anti-Tumor Therapy|September 1, 2022
The clinical advances of proteolysis targeting chimeras in oncologyHao Xie, Junjia Liu, Diego M Alem Glison, et al.Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Interface between obesity with dysfunctional metabolism and inflammation, and the triple-negative breast cancer in African American womenKatarzyna RygielExploration of Targeted Anti-Tumor Therapy|September 1, 2022
Alterations in the Ca2+ toolkit in oesophageal adenocarcinomaAlana L Cutliffe, Sharon L McKenna, Darshan S Chandrashekar, et al.Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institutionDaniele Ugo Tari, Rosalinda Santonastaso, Fabio PintoExploration of Targeted Anti-Tumor Therapy|September 1, 2022
Targeting the two-pore channel 2 in cancer progression and metastasisKathryn A Skelding, Daniel L Barry, Danielle Z Theron, et al.Pageof 39